Skip to main content
NCBI home page
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1984 Aug;60(4):258–264. doi: 10.1136/sti.60.4.258

Epstein-Barr (EB) virus infection in homosexual men in London.

D H Crawford, I Weller, V Iliescu, D W Wara
PMCID: PMC1046322  PMID: 6331569

Abstract

Twenty five homosexual men from London, 14 of whom had persistent lymphadenopathy and 11 of whom did not, were tested for immunity to Epstein-Barr (EB) virus. All yielded positive results to serological tests for the viral capsid antibody, and 11 had antibodies to the early antigen. Thirteen out of 17 were excreting virus into the saliva; culture of peripheral blood mononuclear cells from two of these patients showed no detectable regression induced by T cells that was specific to EB virus. No differences were found between the patients with and without lymphadenopathy. Peripheral blood B cells from six patients with hypergammaglobulinaemia were double stained for cytoplasmic immunoglobulin and EB viral nuclear antigen, and in all cases the activated B cells producing immunoglobulin did not contain EB nuclear antigen. Similarly, lymph node biopsy specimens from five patients showed no cells with EB nuclear antigen. These results indicate that although homosexual men have a high incidence of reactivated infection with EB virus, this viral infection is not the cause of the polyclonal activation of B cells seen in peripheral blood and is not implicated in the aetiology of the lymphadenopathy found in these men.

Full text

PDF
258

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beverley P. C., Callard R. E. Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody. Eur J Immunol. 1981 Apr;11(4):329–334. doi: 10.1002/eji.1830110412. [DOI] [PubMed] [Google Scholar]
  2. Craig J. C., Haire M., Millar J. H., Fraser K. B., Merrett J. D. Immunological control of Epstein-Barr virus-transformed lymphocytes in multiple sclerosis. Clin Immunol Immunopathol. 1983 Oct;29(1):86–93. doi: 10.1016/0090-1229(83)90009-0. [DOI] [PubMed] [Google Scholar]
  3. Crawford D. H., Edwards J. M., Sweny P., Hoffbrand A. V., Janossy G. Studies on long-term T-cell-mediated immunity to Epstein-BArr virus in immunosuppressed renal allograft recipients. Int J Cancer. 1981 Dec;28(6):705–709. doi: 10.1002/ijc.2910280608. [DOI] [PubMed] [Google Scholar]
  4. Crawford D. H., Sweny P., Edwards J. M., Janossy G., Hoffbrand A. V. Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet. 1981 Jan 3;1(8210):10–12. doi: 10.1016/s0140-6736(81)90115-x. [DOI] [PubMed] [Google Scholar]
  5. Crawford D. H., Thomas J. A., Janossy G., Sweny P., Fernando O. N., Moorhead J. F., Thompson J. H. Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet. 1980 Jun 21;1(8182):1355–1356. doi: 10.1016/s0140-6736(80)91800-0. [DOI] [PubMed] [Google Scholar]
  6. Fauci A. S. The syndrome of Kaposi's sarcoma and opportunistic infections: an epidemiologically restricted disorder of immunoregulation. Ann Intern Med. 1982 Jun;96(6 Pt 1):777–779. doi: 10.7326/0003-4819-96-6-777. [DOI] [PubMed] [Google Scholar]
  7. Fernandez R., Mouradian J., Metroka C., Davis J. The prognostic value of histopathology in persistent generalized lymphadenopathy in homosexual men. N Engl J Med. 1983 Jul 21;309(3):185–186. doi: 10.1056/NEJM198307213090314. [DOI] [PubMed] [Google Scholar]
  8. Gaston J. S., Rickinson A. B., Epstein M. A. Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients. Rheumatol Int. 1982;2(4):155–159. doi: 10.1007/BF00286137. [DOI] [PubMed] [Google Scholar]
  9. Gerber P., Lucas S., Nonoyama M., Perlin E., Goldstein L. I. Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet. 1972 Nov 11;2(7785):988–989. doi: 10.1016/s0140-6736(72)92402-6. [DOI] [PubMed] [Google Scholar]
  10. Groopman J. E., Gottlieb M. S. Acquired immune deficiency syndrome. AIDS: the widening gyre. Nature. 1983 Jun 16;303(5918):575–576. doi: 10.1038/303575a0. [DOI] [PubMed] [Google Scholar]
  11. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 1970 Jul 10;169(3941):188–190. doi: 10.1126/science.169.3941.188. [DOI] [PubMed] [Google Scholar]
  13. Hewetson J. F., Rocchi G., Henle W., Henle G. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis. J Infect Dis. 1973 Sep;128(3):283–289. doi: 10.1093/infdis/128.3.283. [DOI] [PubMed] [Google Scholar]
  14. Kaplan M. E., Clark C. An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods. 1974 Jul;5(2):131–135. doi: 10.1016/0022-1759(74)90003-9. [DOI] [PubMed] [Google Scholar]
  15. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  16. Lederman M. M., Ratnoff O. D., Scillian J. J., Jones P. K., Schacter B. Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med. 1983 Jan 13;308(2):79–83. doi: 10.1056/NEJM198301133080205. [DOI] [PubMed] [Google Scholar]
  17. Miller G. Epstein-Barr herpesvirus and infectious mononucleosis. Prog Med Virol. 1975;20:84–112. [PubMed] [Google Scholar]
  18. Miller G., Shope T., Lisco H., Stitt D., Lipman M. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci U S A. 1972 Feb;69(2):383–387. doi: 10.1073/pnas.69.2.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Moll B., Emeson E. E., Small C. B., Friedland G. H., Klein R. S., Spigland I. Inverted ratio of inducer to suppressor T-lymphocyte subsets in drug abusers with opportunistic infections. Clin Immunol Immunopathol. 1982 Dec;25(3):417–423. doi: 10.1016/0090-1229(82)90206-9. [DOI] [PubMed] [Google Scholar]
  20. Morris L., Distenfeld A., Amorosi E., Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med. 1982 Jun;96(6 Pt 1):714–717. doi: 10.7326/0003-4819-96-6-714. [DOI] [PubMed] [Google Scholar]
  21. Moss D. J., Rickinson A. B., Pope J. H. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer. 1978 Dec;22(6):662–668. doi: 10.1002/ijc.2910220604. [DOI] [PubMed] [Google Scholar]
  22. Nilsson K., Klein G., Henle W., Henle G. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer. 1971 Nov 15;8(3):443–450. doi: 10.1002/ijc.2910080312. [DOI] [PubMed] [Google Scholar]
  23. Pattengale P. K., Smith R. W., Gerber P. Selective transformation of B lymphocytes by E.B. virus. Lancet. 1973 Jul 14;2(7820):93–94. doi: 10.1016/s0140-6736(73)93286-8. [DOI] [PubMed] [Google Scholar]
  24. Penn I. Tumor incidence in human allograft recipients. Transplant Proc. 1979 Mar;11(1):1047–1051. [PubMed] [Google Scholar]
  25. Pitchenik A. E., Fischl M. A., Dickinson G. M., Becker D. M., Fournier A. M., O'Connell M. T., Colton R. M., Spira T. J. Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann Intern Med. 1983 Mar;98(3):277–284. doi: 10.7326/0003-4819-98-3-277. [DOI] [PubMed] [Google Scholar]
  26. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. doi: 10.1002/ijc.2910110302. [DOI] [PubMed] [Google Scholar]
  27. Rickinson A. B., Wallace L. E., Epstein M. A. HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells. Nature. 1980 Feb 28;283(5750):865–867. doi: 10.1038/283865a0. [DOI] [PubMed] [Google Scholar]
  28. Robinson J. E., Smith D., Niederman J. Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis. J Exp Med. 1981 Feb 1;153(2):235–244. doi: 10.1084/jem.153.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rosén A., Gergely P., Jondal M., Klein G., Britton S. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature. 1977 May 5;267(5606):52–54. doi: 10.1038/267052a0. [DOI] [PubMed] [Google Scholar]
  30. Sonnabend J., Witkin S. S., Purtilo D. T. Acquired immunodeficiency syndrome, opportunistic infections, and malignancies in male homosexuals. A hypothesis of etiologic factors in pathogenesis. JAMA. 1983 May 6;249(17):2370–2374. [PubMed] [Google Scholar]
  31. Stahl R. E., Friedman-Kien A., Dubin R., Marmor M., Zolla-Pazner S. Immunologic abnormalities in homosexual men. Relationship to Kaposi's sarcoma. Am J Med. 1982 Aug;73(2):171–178. doi: 10.1016/0002-9343(82)90174-7. [DOI] [PubMed] [Google Scholar]
  32. Strauch B., Andrews L. L., Siegel N., Miller G. Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet. 1974 Feb 16;1(7851):234–237. doi: 10.1016/s0140-6736(74)92546-x. [DOI] [PubMed] [Google Scholar]
  33. Ziegler J. L., Drew W. L., Miner R. C., Mintz L., Rosenbaum E., Gershow J., Lennette E. T., Greenspan J., Shillitoe E., Beckstead J. Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet. 1982 Sep 18;2(8299):631–633. doi: 10.1016/s0140-6736(82)92740-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES